FDA Drug Application (021204) for STARLIX by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number021204
Product Number001
FormTABLET;ORAL
Dosage60MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSTARLIX
Active IngredientNATEGLINIDE

Active IngredientCount
List of drugs with Active Ingredient NATEGLINIDE2


Back to FDA Applications sponsored by NOVARTIS